These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 27725164)

  • 1. Tamoxifen for the treatment of breakthrough bleeding with the etonogestrel implant: a randomized controlled trial.
    Simmons KB; Edelman AB; Fu R; Jensen JT
    Contraception; 2017 Feb; 95(2):198-204. PubMed ID: 27725164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Unfavorable Bleeding Patterns in Contraceptive Implant Users: A Randomized Controlled Trial.
    Edelman AB; Kaneshiro B; Simmons KB; Hauschildt JL; Bond K; Boniface ER; Jensen JT
    Obstet Gynecol; 2020 Aug; 136(2):323-332. PubMed ID: 32649493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of unfavorable bleeding patterns in contraceptive implant users: a randomized clinical trial of curcumin.
    Edelman A; Boniface E; Schrote K; Messerle-Forbes M; O'Donnell A; Jensen JT; Han L
    Am J Obstet Gynecol; 2023 Aug; 229(2):145.e1-145.e9. PubMed ID: 37116825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ulipristal Acetate for Unscheduled Bleeding in Etonogestrel Implant Users: A Randomized Controlled Trial.
    Zigler RE; Madden T; Ashby C; Wan L; McNicholas C
    Obstet Gynecol; 2018 Oct; 132(4):888-894. PubMed ID: 30130351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined oral contraceptive treatment for bleeding complaints with the etonogestrel contraceptive implant: a randomised controlled trial.
    Hou MY; McNicholas C; Creinin MD
    Eur J Contracept Reprod Health Care; 2016 Oct; 21(5):361-6. PubMed ID: 27419258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamoxifen for the prevention of unscheduled bleeding in new users of the levonorgestrel 52-mg intrauterine system: a randomized controlled trial.
    Cohen MA; Simmons KB; Edelman AB; Jensen JT
    Contraception; 2019 Nov; 100(5):391-396. PubMed ID: 31226322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot study to assess the effect of three short-term treatments on frequent and/or prolonged bleeding compared to placebo in women using Implanon.
    Weisberg E; Hickey M; Palmer D; O'Connor V; Salamonsen LA; Findlay JK; Fraser IS
    Hum Reprod; 2006 Jan; 21(1):295-302. PubMed ID: 16284061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a single dose of a combination injectable contraceptive for treatment of bothersome uterine bleeding in contraceptive implant(s) users: A randomized double-blind placebo-controlled trial.
    Sinthuchai N; Tapanwong N; Apirakviriya C; Pohthipornthawat N; Santibenchakul S; Jaisamrarn U
    Contraception; 2024 Mar; 131():110354. PubMed ID: 38103854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of rifampin on serum etonogestrel concentrations and biomarkers of ovulation among contraceptive implant users: A pharmacokinetic and pharmacodynamic study.
    Lazorwitz A; Sheeder J; Teal S
    Contraception; 2023 Jul; 123():110035. PubMed ID: 36997081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel.
    Funk S; Miller MM; Mishell DR; Archer DF; Poindexter A; Schmidt J; Zampaglione E;
    Contraception; 2005 May; 71(5):319-26. PubMed ID: 15854630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 12-month multicenter, randomized study comparing the levonorgestrel intrauterine system with the etonogestrel subdermal implant.
    Apter D; Briggs P; Tuppurainen M; Grunert J; Lukkari-Lax E; Rybowski S; Gemzell-Danielsson K
    Fertil Steril; 2016 Jul; 106(1):151-157.e5. PubMed ID: 27016644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression associated with unfavorable vaginal bleeding in women using the etonogestrel subdermal contraceptive implant: a prospective study.
    Torelli FR; Rodrigues-Peres RM; Monteiro I; Lopes-Cendes I; Bahamondes L; Juliato CRT
    Sci Rep; 2024 May; 14(1):11062. PubMed ID: 38745005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-Term Treatment of Bothersome Bleeding for Etonogestrel Implant Users Using a 14-Day Oral Contraceptive Pill Regimen: A Randomized Controlled Trial.
    Guiahi M; McBride M; Sheeder J; Teal S
    Obstet Gynecol; 2015 Sep; 126(3):508-513. PubMed ID: 26181091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of efficacy, cycle control, and tolerability of two low-dose oral contraceptives in a multicenter clinical study.
    Endrikat J; Düsterberg B; Ruebig A; Gerlinger C; Strowitzki T
    Contraception; 1999 Nov; 60(5):269-74. PubMed ID: 10717778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol.
    Akerlund M; Røde A; Westergaard J
    Br J Obstet Gynaecol; 1993 Sep; 100(9):832-8. PubMed ID: 8218004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized study of the effect of mifepristone alone or in conjunction with ethinyl estradiol on ovarian function in women using the etonogestrel-releasing subdermal implant, Implanon®.
    Weisberg E; Croxatto HB; Findlay JK; Burger HG; Fraser IS
    Contraception; 2011 Dec; 84(6):600-8. PubMed ID: 22078189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged use of the etonogestrel implant and levonorgestrel intrauterine device: 2 years beyond Food and Drug Administration-approved duration.
    McNicholas C; Swor E; Wan L; Peipert JF
    Am J Obstet Gynecol; 2017 Jun; 216(6):586.e1-586.e6. PubMed ID: 28147241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized comparison of bleeding patterns in women using a combined contraceptive vaginal ring or a low-dose combined oral contraceptive on a menstrually signaled regimen.
    Weisberg E; Merki-Feld GS; McGeechan K; Fraser IS
    Contraception; 2015 Feb; 91(2):121-6. PubMed ID: 25459098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immediate versus delayed insertion of an etonogestrel releasing implant at medical abortion-a randomized controlled equivalence trial.
    Hognert H; Kopp Kallner H; Cameron S; Nyrelli C; Jawad I; Heller R; Aronsson A; Lindh I; Benson L; Gemzell-Danielsson K
    Hum Reprod; 2016 Nov; 31(11):2484-2490. PubMed ID: 27664217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A contraceptive subdermal implant releasing the progestin ST-1435: ovarian function, bleeding patterns, and side effects.
    Laurikka-Routti M; Haukkamaa M
    Fertil Steril; 1992 Dec; 58(6):1142-7. PubMed ID: 1459263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.